PL396649A1 - Zapobieganie oraz ograniczanie wystepowania niekontrolowanych spadków poziomu cukru, u chorych na cukrzyce - Google Patents

Zapobieganie oraz ograniczanie wystepowania niekontrolowanych spadków poziomu cukru, u chorych na cukrzyce

Info

Publication number
PL396649A1
PL396649A1 PL396649A PL39664911A PL396649A1 PL 396649 A1 PL396649 A1 PL 396649A1 PL 396649 A PL396649 A PL 396649A PL 39664911 A PL39664911 A PL 39664911A PL 396649 A1 PL396649 A1 PL 396649A1
Authority
PL
Poland
Prior art keywords
blood sugar
patients
diabetes
occurrence
preventing
Prior art date
Application number
PL396649A
Other languages
English (en)
Inventor
Tomasz Banasiewicz
Łukasz Krokowicz
Paweł Andrzej Michałowski
Original Assignee
Tomasz Banasiewicz
Łukasz Krokowicz
Paweł Andrzej Michałowski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomasz Banasiewicz, Łukasz Krokowicz, Paweł Andrzej Michałowski filed Critical Tomasz Banasiewicz
Priority to PL396649A priority Critical patent/PL396649A1/pl
Priority to PCT/PL2012/000103 priority patent/WO2013055245A1/en
Publication of PL396649A1 publication Critical patent/PL396649A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

Wynalazek rozwiazuje zagadnienie ograniczenia niekontrolowanych spadków poziomu cukru u chorych na cukrzyce, w szczególnosci w czasie snu, w godzinach 22-04 rano, poprzez kontrolowane, rozlozone w czasie uwalnianie glukozy, przez co zasila sie organizm w ciagu 5-6 godzin glukoza. Istota wynalazku polega na zastosowaniu mieszaniny chronionej glukozy wraz z niechroniona krystaliczna glukoza i maltodektryna w zywieniu chorych na cukrzyce.
PL396649A 2011-10-14 2011-10-14 Zapobieganie oraz ograniczanie wystepowania niekontrolowanych spadków poziomu cukru, u chorych na cukrzyce PL396649A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL396649A PL396649A1 (pl) 2011-10-14 2011-10-14 Zapobieganie oraz ograniczanie wystepowania niekontrolowanych spadków poziomu cukru, u chorych na cukrzyce
PCT/PL2012/000103 WO2013055245A1 (en) 2011-10-14 2012-10-12 Prevention and reduction of uncontrolled decrease of blood glucose levels in diabetic patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL396649A PL396649A1 (pl) 2011-10-14 2011-10-14 Zapobieganie oraz ograniczanie wystepowania niekontrolowanych spadków poziomu cukru, u chorych na cukrzyce

Publications (1)

Publication Number Publication Date
PL396649A1 true PL396649A1 (pl) 2013-04-15

Family

ID=47297375

Family Applications (1)

Application Number Title Priority Date Filing Date
PL396649A PL396649A1 (pl) 2011-10-14 2011-10-14 Zapobieganie oraz ograniczanie wystepowania niekontrolowanych spadków poziomu cukru, u chorych na cukrzyce

Country Status (2)

Country Link
PL (1) PL396649A1 (pl)
WO (1) WO2013055245A1 (pl)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997038593A1 (en) * 1996-04-12 1997-10-23 Beth Israel Deaconess Medical Center, Inc. Diabetic supplement bar
US6953593B2 (en) * 2000-02-01 2005-10-11 Lipoprotein Technologies, Inc. Sustained-release microencapsulated delivery system

Also Published As

Publication number Publication date
WO2013055245A1 (en) 2013-04-18

Similar Documents

Publication Publication Date Title
PH12018500767A1 (en) Pharmaceutical composition, methods for treating and uses thereof
EP2723229A4 (en) UNIFORM PLATFORM FOR MONITORING AND CONTROLLING THE BLOOD SUGAR MIRROR IN DIABETES PATIENTS
WO2012174480A3 (en) Continuous subcutaneous insulin infusion methods with a hyaluronan degrading enzyme
IL250549B (en) Acetyl analogs of insulin that are resistant to protease and their use for the preparation of a drug for the treatment and prevention of diabetes
ZA201503110B (en) Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
MX348564B (es) Tetrahidrocannabivarina para usarse en la protección de células de los islotes pancreáticos.
MY176863A (en) Ibat inhibitors for treatment of metabolic disorders and related conditions
WO2011107755A3 (en) Immediate/delayed drug delivery
MX2013009948A (es) Composiciones de insulina y cromo para el tratamiento y prevencion de diabetes, hipoglucemia y alteraciones relacionadas.
MX362503B (es) Combinacion farmaceutica para mejorar el control glucemico como terapia adicional a la insulina basal.
EP2605819A4 (en) INSULIN INJECTION PIN WITH INTEGRATED BLOOD MONITOR MONITOR AND AUTOMATIC EMERGENCY NOTIFICATION
BR112013021125A2 (pt) método para regular os níveis de glicose no sangue, método para aumentar a secreção da insulina ou promover a liberação da insulina na corrente sanguínea, método para tratar uma doença ou condição, método para retardar o ínicio de uma doença ou condição de doença kit, composto de composição farmacêutica
PL385586A1 (pl) Nowe analogi insuliny o przedłużonym działaniu
MX2013004699A (es) Combinaciones farmaceuticas para el tratamiento de trastornos metabolicos.
NZ603614A (en) Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
MX2013013307A (es) Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2.
MX2013008484A (es) Prevencion de hidroglucemia en pacientes con diabetes mellitus tipo 2.
PH12015501931B1 (en) Treatment of diabetes mellitus by long-acting formulations of insulins
IL223434A (en) Methods in n-acetylneuraminic acid, a precursor of n-acetylneuraminic acid or their combination in the preparation of a drug for the treatment of diabetic conditions and a method for determining the status of a subject in relation to nephrotic syndrome or diabetic conditions
PL396649A1 (pl) Zapobieganie oraz ograniczanie wystepowania niekontrolowanych spadków poziomu cukru, u chorych na cukrzyce
WO2012047628A3 (en) Methods of managing blood sugar levels and compositions related thereto
EP2445338A4 (en) SYNERGISTIC COMBINATION FOR IMPROVING METABOLISM OF INSULIN AND BLOOD GLUCOSE
WO2012105816A3 (ko) 새콩 분말 또는 이의 추출물을 포함하는 당뇨병 및 당뇨합병증 예방 및 치료를 위한 조성물
WO2012123519A3 (en) Human insulin analogues and derivatives comprising cysteine substitutions
WO2014014819A3 (en) Methods of treating glucose metabolism disorders